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Abstract
Intranodal palisaded myofibroblastoma is a rare benign soft tissue tumor, almost always arising from inguinal
lymph nodes. It usually presents as a painless, slow-growing inguinal mass. We report herein a case of an intrano-
dal palisaded myofibroblastoma occurring in a 36-year-old man. The salient clinicopathologic features of this unu-
sual tumor are presented and the literature is briefly reviewed.
Introduction
Intranodal palisaded myofibroblastoma (IPM) also called
as intranodal hemorrhagic spindle cell tumor with
amianthoid fiber is a rare benign tumour of the lymph
node that may be derived from myofibroblasts or
smooth muscle cells. The most usual area of presenta-
tion is the inguinal lymph nodes, but occurrence within
other areas such as mediastinum and submandibular
lymph nodes has also been reported [1]. This unusual
lesion was first well characterized in 1989. Previous
reports of similar cases in the literature were considered
to represent intranodal primary or metastatic neurile-
moma. To our knowledge, approximately 53 such cases
have been reported in the literature [2]. The ages of
patients ranged from 19 to 78 years with a slight male
predominance [3,4].
Case presentation
A 36-year-old Greek Caucasian male patient presented
with a slowly growing lump in his right groin. He men-
tioned that he first noticed the swelling two years ago.
There were no symptoms associated with it. In physical
examination, a solitary, painless, mobile, firm mass was
determined in the right inguinal region of the patient.
He had no other significant findings in physical exami-
nation or clinical work-up. The lesion was excised for
diagnostic purposes. The specimen consisted of a well
circumscribed mass measuring 2.5 cm in diameter. Its
cut surface was whitish, nodular and firm. Representa-
tive sections of the specimen revealed a lymph node
almost replaced by a spindle cell tumor (Figure 1) con-
sisting of cells with bland nuclear features and no signif-
icant mitotic activity. In several areas, nuclear palisading
was noted and in these areas the tumor was reminiscent
of a schwannoma. Focal stellate-shaped acellular eosino-
philic structures were identified in the stroma (Figure
2). Immunohistochemical analysis showed that the neo-
plastic cells were positive for cyclin D1 (Figure 3) and
smooth muscle actin, whereas they were negative for S-
100 protein, cytokeratin, melan A, CD34, desmin and
EMA. In this clinical setting, the morphology of the
tumor along with its immunohistochemical findings
were characteristic for an intranodal palisaded
myofibroblastoma.
Discussion
Intranodal palisaded myofibroblastoma is a benign
tumor which has a great predilection for the inguinal
lymph nodes. Submandibular and cervical lymph nodes
have also been reported as rare originating sites [3]. It
was first well characterized in 1989 in two series of
patients that were reported in the literature under the
names of palisaded myofibroblastoma [5] and intranodal
hemorrhagic spindle cell tumor with amianthoid fibers
[6]. Clinically, it presentsa sa na s y m p t o m a t i c ,s l o w l y
growing tumor. It is more common in males and it is
diagnosed at a wide age range (from 19 to 78 years) [3].
Its size varies from 0.6 to 5 cm [4].
Its predominant morphologic features include the
bland appearance of its constituent spindle cell popula-
tion and the presence of acellular eosinophilic stellate
areas (so-called amianthoid fibers). As an intranodal
lesion, intranodal palisaded myofibroblastoma grows
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outwardly to the periphery; thus, normal lymphoid tis-
sue is compressed to the periphery.
The immunohistochemical profile of the neoplastic
cells along with their ultrastructural features is indica-
tive of myofibroblastic or smooth muscle differentia-
tion [5,6]. Intranodal palisaded myofibroblastoma has
recently been shown to have a strong expression for
cyclin D1 and a low proliferating index of Ki- 67 [7].
The overexpression of cyclin D1 presented in the
study of Kleist et al, points to the proliferation regula-
tory pathway as one of the factors involved in the etio-
logic pathogenesis of intranodal palisaded
myofibroblastoma [7]. It is negative for neural markers
such as S100, and endothelial markers such as CD34,
and desmin.
T h ep r e s e n c eo fas p i n d l ec e l ln e o p l a s mi nal y m p h
node requires a thorough clinical work - up to identify a
primary neoplasm. Metastatic spindle squamous cell car-
cinoma, melanoma, sarcomatoid renal cell carcinoma
are examples of carcinomas that can present as spindle
cell lymph node lesions. Metastatic sarcomas should
also be included in the differential diagnosis. Spindle
cell tumors that arise primarily in lymph nodes are
Kaposi sarcoma, dendritic cell tumor and benign
mesenchymal tumors such as neurofibroma [5]. Schwan-
nomas are unlikely to occur within the lymph nodes,
due to the fact that they arise from Schwann cells of the
nerve sheath, which do not innervate lymph nodes.
Furthermore, intranodal palisaded myofibroblastoma
lacks Antoni A type A and B areas and does not express
S100 protein. Nuclear palisading, amianthoid-like
changes and the lack of a history of immunocompro-
mised status distinguish intanodal palisaded myofibro-
blastoma from Kaposi sarcoma. In order to exlude
hemangioendothelioma from the differential diagnosis,
expression of endothelial markers such as CD34 and
CD31 should be performed during the immunohisto-
chemical analysis. Finally, one must rule out the possibi-
lity of metastases from malignant melanoma and
sarcoma based on thorough clinical history and an
appropriate immunohistochemical profile.
Although a wide range of soft tissue tumors can be
included in the differential diagnosis, intranodal pali-
saded myofibroblastoma has a distinctive morphological
feature and an immunohistochemical profile. When the
diagnosis is suspected, it is best to report this lesion as a
low grade spindle cell tumor and recommend surgical
excision. Excellent prognosis has been reported after
s u r g i c a lt r e a t m e n tw i t ha6 %r e c u r r e n c er a t ea n dn o
malignant transformation [3].
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
images. A copy of the written consent is available for
review by the journal’s Editor-in-Chief.
Figure 1 Intranodal palisaded myofibroblastoma with a thin
rim of residual lymph node at the periphery (hematoxylin-
eosin ×25).
Figure 2 Amianthoid fibers (hematoxylin-eosin ×100).
Figure 3 Cyclin D1 positive tumor cells (immunohistochemistry
×100).
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